Aptus Pharma Limited IPO
Aptus Pharma Limited is engaged in the marketing and distribution of finished pharmaceutical formulations. Converted into a public limited company in December 2024, it operates under a contract manufacturing model without owning manufacturing facilities. The company partners with seven manufacturing units, including formal loan and license agreements with two units, while the rest function through purchase order-based arrangements. Its diverse product portfolio spans multiple therapeutic categories—such as anti-infectives, gastrointestinal, cardiovascular, anti-diabetic, neuro-psychiatric, and wellness products—offered in varied dosage forms including tablets, capsules, syrups, injections, ointments, and more.
Price Band₹65 - ₹70 |
Dates23 Sep - 25 Sep |
GMP₹0 (0.00%) |
Subscriptions20.79 times |
Issue Size₹13.02 Crs |
Aptus Pharma IPO Key Dates
Opening Date
23 Sep 25
Closing Date
25 Sep 25
Basis Of Allotment
26 Sep 25
Initiations Of Refund
29 Sep 25
Credit Of Shares
29 Sep 25
Listing Date
30 Sep 25
Aptus Pharma IPO Objects
- Capital Expenditure for Office Premises with furniture and Industrial Racks
- Working Capital
- General corporate purposes
Aptus Pharma IPO Details
Price Band₹65 - ₹70 |
Listing AtBSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹13.02 Cr (0.19 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹13.02 Cr (0.19 Cr Shares) |
Face Value₹10 per equity share |
Aptus Pharma IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
4,000
2,80,000
Maximum
2
4,000
2,80,000
|
|||
| Small HNI |
Minimum
3
6,000
4,20,000
Maximum
7
14,000
9,80,000
|
|||
| Big HNI |
Minimum
8
16,000
11,20,000
|
|||
Aptus Pharma IPO Subscription
Updated as on 25 Sep 2025 | 05:00:00 PM
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 1.24 | 3,52,000 | 4,36,000 |
| NII | 21.51 | 2,66,000 | 77,42,000 |
| bNII (bids above ₹10L) | 31.17 | 1,78,000 | 55,48,000 |
| sNII (bids between ₹2L to ₹10L) | 24.93 | 88,000 | 21,94,000 |
| Retail | 31.48 | 6,20,000 | 1,95,20,000 |
| Total | 20.79 | 13,32,000 | 2,76,98,000 |
Aptus Pharma IPO GMP
The estimated Grey Market Premium of Aptus Pharma IPO is ₹0 per share (0.00%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than 35% of Net Offer |
| Retail | Not less than 15% of Net Offer |
| Market Maker | 94000 EQ Shares |
Aptus Pharma IPO Financials
Key Performance Indicators
| KPI | Values |
|---|---|
| EBITDA | 19.31% |
| PAT | 12.62% |
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt to Equity | 1.49 |
| PE Ratio | 10.99 |
| PB Ratio | 5.03 |
| Mkt Cap (in Crs.) | 48.02 |
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Aptus Pharma IPO Peer Comparision
Aptus Pharma IPO Peer Comparision
Promoter Details
| Name | Shareholding |
|---|---|
| Tejash Maheshchandra Hathi | 15.50% |
| Kapilbhai Hasmukhbhai Chandarana | 15.50% |
| Others | 69.00% |
| Total | 100.00% |
Management Details
| Name | Designation |
|---|---|
| Tejash Maheshchandra Hathi | MD |
| Kapilbhai Chandarana | CFO |
Company Details
Name: Aptus Pharma Limited
Address: Ashutosh
Buildcon, Opp. Slok - 2, Nr.
Harikrupa Logistic Park, Aslali,
Ahmedabad, Daskroi, Gujarat, India,
382427
Number: +91 76004 27827
Email: info@aptuspharma.com
Website: www.aptus-pharma.com
Book Running Lead Managers (BRLMs)
RTAs
Bigshare Services
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Aptus Pharma IPO is a SME IPO having an issue size of Rs. ₹13.02 Crs. Aptus Pharma IPO is priced at ₹65 - ₹70 per share. The issue opens on 23 Sep 25 and closes on 25 Sep 25.
Aptus Pharma IPO opens on 23 Sep 25 and closes on 25 Sep 25.
The estimated Grey Market Premium of Aptus Pharma IPO is ₹0 per share (0.00%).
The minimum lot size of Aptus Pharma IPO is 2000 shares & the minimum application amount is Rs. 140000.
The allotment date of Aptus Pharma IPO is 26 Sep 25.
The listing date of Aptus Pharma IPO is 30 Sep 25.
Aptus Pharma IPO is subscribed 20.79 times.
Aptus Pharma IPO is priced at ₹65 - ₹70 per share.
Click the allotment link on Aptus Pharma IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Aptus Pharma IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
